+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Medical Marijuana Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4701685
  • Report
  • Region: Global
  • Acute Market Reports
1 of 3

FEATURED COMPANIES

  • AbbVie, Inc.
  • CannaGrow Holdings, Inc.
  • GW Pharmaceuticals, Plc.
  • Insys Therapeutics, Inc.
  • Lexaria Corporation
  • Novartis AG
  • MORE
Medical Marijuana Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026, the global medical marijuana market was valued at US$ 13,908.7 Mn in 2017, and is expected to reach US$ 57,582.5 Mn by 2026, expanding at a CAGR of 17.1% from 2018 to 2026.

Market Insights
Cannabionoids are natural extracts derived from Cannabis sativa, Cannabis indica and Cannabis ruderalis. For centuries marijuana has been used extensively for recreational, medical and ritualistic purposes. It comprises of psychoactive drug component tetrahydrocannabinol which causes the stimulation of the cannabinoid receptor CB1 and CB2 respectively. The activation of these receptors results in pain relieving activity in patients suffering with chronic pain due to AIDS, cancer, neuropathic pain etc.,

In the last decade marijuana has been a keen research subject for researchers and academicians throughout the globe to understand its therapeutic benefits in treating anorexia and nausea. Positive steps have been taken by healthcare and law enforcing agencies to legalize the production and sale of marijuana for medicinal purpose. Tremendous focus is laid in drafting guidelines for the judicious use of marijuana in healthcare centers. Nowadays marijuana is available as weed infused gums, tampons, cannabinoid infused tea, bath salts, cannabinoid infused coffee and topical balms to get relief from pain.

Cancer is currently dominating the applications segment on account of large patient pool suffering with chronic pain and nausea during chemotherapy. Marijuana have been found beneficial in treating patients with neurological disorders such as epilepsy, seizures etc., due to its sedative effects. Chronic pain will gain momentum due to increasing number of patients suffering with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis and other autoimmune diseases such as psoriasis and multiple sclerosis.

In the present scenario hospital pharmacies are dominating the point of sale segment on account of key parameters such as availability of medical marijuana at low cost and strict monitoring of cancer patients availing marijuana for treating chronic pain. Dispensaries will register good growth during the forecast period due to increasing number of patients suffering with anorexia and nausea and government permit to dispense marijuana on regular basis to patients suffering with chronic pain.

North America is the global leader in medical marijuana market owing to the rising prevalence of cancer and proactive policies implemented by USFDA legalizing the production and sale of marijuana for treating chronic pain. Germany has drafted regulatory guidelines for the use of marijuana for medicinal purpose which also serves as a gold standard for other European Union countries. Rest of the World serves as a lucrative market as it is the largest producer of marijuana in the world and regulatory agencies are taking proactive steps to legalize the production and sale of marijuana for therapeutic use.

The key players actively engaged in the production and sale of marijuana are AbbVie, Inc., CannaGrow Holdings, Inc., Canopy Growth Corporation, Inc., GW Pharmaceuticals, Plc. Insys Therapeutics, Inc., Novartis AG, Lexaria Corporation, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and United Cannabis Corporation.

Key Market Movements:
  • Rising prevalence of cancer and patients suffering with chronic pain
  • Increased research funding for determining the therapeutic efficacy of marijuana for treating anorexia and nausea
  • Supportive regulatory environment for the production and sale of marijuana for medicinal purposes
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie, Inc.
  • CannaGrow Holdings, Inc.
  • GW Pharmaceuticals, Plc.
  • Insys Therapeutics, Inc.
  • Lexaria Corporation
  • Novartis AG
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Medical Marijuana Market Portraiture
2.2. Global Medical Marijuana Market, by Application, 2017 (US$ Mn)
2.3. Global Medical Marijuana Market, by Point of Sale, 2017 (US$ Mn)
2.4. Global Medical Marijuana Market, by Geography, 2017 (US$ Mn)

Chapter 3. Medical Marijuana Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Medical Marijuana Market, by Key Players, 2017

Chapter 4. Global Medical Marijuana Market, by Application
4.1. Overview
4.2. Chronic Pain
4.3. Neurological Disorders
4.4. Cancer
4.5. Others (Anorexia, Nausea etc.)

Chapter 5. Global Medical Marijuana Market, by Point of Sale
5.1. Overview
5.2. Hospital Pharmacy
5.3. Dispensaries

Chapter 6. Global Medical Marijuana Market, by Geography
6.1. Overview
6.2. North America Medical Marijuana Market Analysis, 2016 – 2026
6.2.1. North America Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
6.2.2. North America Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.2.3. North America Medical Marijuana Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Medical Marijuana Market Analysis, 2016 – 2026
6.3.1. Europe Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
6.3.2. Europe Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.3.3. Europe Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Latin America Medical Marijuana Market Analysis, 2016 – 2026
6.4.1. Latin America Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
6.4.2. Latin America Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.4.3. Latin America Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Rest of World Medical Marijuana Market Analysis, 2016 – 2026
6.5.1. RoW Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
6.5.2. RoW Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.5.3. RoW Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Australia
6.5.3.2. Israel
6.5.3.3. Rest of World

Chapter 7. Company Profiles
7.1. AbbVie, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. CannaGrow Holdings, Inc.
7.3. Canopy Growth Corporation, Inc.
7.4. GW Pharmaceuticals, Plc.
7.5. Insys Therapeutics, Inc.
7.6. Novartis AG
7.7. Lexaria Corporation
7.8. Pfizer, Inc.
7.9. Teva Pharmaceutical Industries Ltd.
7.10. United Cannabis Corporation

List of Figures
FIG. 1 Medical Marijuana Market: Research Methodology
FIG. 2 Medical Marijuana: Market Segmentation
FIG. 3 Global Medical Marijuana Market, by Application, 2017 (US$ Mn)
FIG. 4 Global Medical Marijuana Market, by Point Of Sale, 2017 (US$ Mn)
FIG. 5 Global Medical Marijuana Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global Medical Marijuana Market, by Key Players, 2017
FIG. 8 Global Chronic Pain Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 9 Global Neurological Disorders Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 10 Global Cancer Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 11 Global Others Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 12 Global Hospital Pharmacy Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 13 Global Dispensaries Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 14 U.S. Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 15 Canada Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 16 U.K. Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 17 Germany Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest of Europe Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 19 Brazil Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 20 Mexico Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Latin America Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 22 Australia Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 23 Israel Medical Marijuana Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest of the World Medical Marijuana Market, 2016 – 2026 (US$ Mn)

List of Tables
TABLE 1 Global Medical Marijuana Market Portraiture
TABLE 2 Global Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 3 Global Medical Marijuana Market , by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 4 Global Medical Marijuana Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 6 North America Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 7 North America Medical Marijuana Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Rest of the World Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 15 Rest of the World Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 16 Rest of the World Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 AbbVie, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 CannaGrow Holdings, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Canopy Growth Corporation, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 GW Pharmaceuticals, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Insys Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Lexaria Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Teva Pharmaceuticals Industries, Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 United Cannabis Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AbbVie, Inc.
  • CannaGrow Holdings, Inc.
  • Canopy Growth Corporation, Inc.
  • GW Pharmaceuticals, Plc.
  • Insys Therapeutics, Inc.
  • Novartis AG
  • Lexaria Corporation
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • United Cannabis Corporation
Note: Product cover images may vary from those shown
Adroll
adroll